Anavex Life Sciences Corp (AVXL)

[sokol]

There is a movement to treat aging as a disease. Age X, Biotime’s subsidiarly, is an example of one of several other companies formed to treat aging. It occurs to me that Anavex’s drugs, AVXL 2-73, and others may be considered antiaging drugs or drugs that treat diseases related to aging, whether it be hypertension, damage to mitochrondia, misfolding of protiens, unexplainable CNS problems that older people are inclined to endure, etc.

I am 76 years old. Fortunately, I remain very active, which is not the case for many of my friends. Remarkably, many of my old friends suffer from CNS disorders such as Parkinson’s, dementia of some sort, and some with unexplainable CNS disorders - doctors simply guessing about the diagnosis using explanations such as possibly spinal strokes, etc. Some of my friends also have cancer or have had cancer, but it seems that in all cases most of the cancers I know of have been treatable whereas the CNS disorders remain untreatable for the most part.

More focus is needed in the area of treating CNS disorders that occur with aging. If aging is recognized as a disease, it will be a way to contain the high cost of medical treatment and care. It will enable people to be functional as they age. Maybe more old people will die being independent and active rather than wasting away in a care facility. If aging is recognized as a disease (and it should be), the medical community should be taking a close look at the drugs Anavex is developing to treat that disease.